JP2016531895A5 - - Google Patents

Download PDF

Info

Publication number
JP2016531895A5
JP2016531895A5 JP2016520004A JP2016520004A JP2016531895A5 JP 2016531895 A5 JP2016531895 A5 JP 2016531895A5 JP 2016520004 A JP2016520004 A JP 2016520004A JP 2016520004 A JP2016520004 A JP 2016520004A JP 2016531895 A5 JP2016531895 A5 JP 2016531895A5
Authority
JP
Japan
Prior art keywords
conjugate
conjugate according
patient
polyethylene glycol
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016520004A
Other languages
English (en)
Japanese (ja)
Other versions
JP6473145B2 (ja
JP2016531895A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/059146 external-priority patent/WO2015051307A1/en
Publication of JP2016531895A publication Critical patent/JP2016531895A/ja
Publication of JP2016531895A5 publication Critical patent/JP2016531895A5/ja
Application granted granted Critical
Publication of JP6473145B2 publication Critical patent/JP6473145B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016520004A 2013-10-04 2014-10-03 Sn−38の徐放性コンジュゲート Active JP6473145B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361887111P 2013-10-04 2013-10-04
US61/887,111 2013-10-04
PCT/US2014/059146 WO2015051307A1 (en) 2013-10-04 2014-10-03 Slow-release conjugates of sn-38

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019010029A Division JP6842479B2 (ja) 2013-10-04 2019-01-24 Sn−38の徐放性コンジュゲート

Publications (3)

Publication Number Publication Date
JP2016531895A JP2016531895A (ja) 2016-10-13
JP2016531895A5 true JP2016531895A5 (https=) 2017-11-09
JP6473145B2 JP6473145B2 (ja) 2019-02-20

Family

ID=51871275

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016520004A Active JP6473145B2 (ja) 2013-10-04 2014-10-03 Sn−38の徐放性コンジュゲート
JP2019010029A Active JP6842479B2 (ja) 2013-10-04 2019-01-24 Sn−38の徐放性コンジュゲート

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019010029A Active JP6842479B2 (ja) 2013-10-04 2019-01-24 Sn−38の徐放性コンジュゲート

Country Status (14)

Country Link
US (2) US10016411B2 (https=)
EP (1) EP3052101B1 (https=)
JP (2) JP6473145B2 (https=)
KR (1) KR102320753B1 (https=)
CN (1) CN106061483B (https=)
AU (2) AU2014331591B2 (https=)
BR (1) BR112016007410B1 (https=)
CA (1) CA2925132C (https=)
DK (1) DK3052101T3 (https=)
ES (1) ES2759905T3 (https=)
MX (1) MX371201B (https=)
SG (2) SG11201602258WA (https=)
TW (1) TWI716342B (https=)
WO (1) WO2015051307A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX371201B (es) * 2013-10-04 2020-01-22 Prolynx Llc Conjugados de liberación lenta de sn-38.
CN107375288B (zh) * 2016-05-16 2019-08-23 博瑞生物医药(苏州)股份有限公司 多臂的聚合靶向抗癌偶联物
KR102279429B1 (ko) 2017-04-21 2021-07-20 브라이트제네 바이오-메디컬 테크놀로지 코., 엘티디. 멀티 암 표적 항암 콘쥬게이트
MX2020007442A (es) * 2018-01-12 2020-09-14 Prolynx Llc Protocolo para minimizar la toxicidad de dosificaciones de combinacion y agente formador de imagen para verificacion.
CA3112778A1 (en) 2018-09-17 2020-03-26 The Children's Hospital Of Philadelphia Polymer-based macromolecular prodrugs
CN119970617A (zh) * 2019-04-05 2025-05-13 普罗林科斯有限责任公司 改良偶联接头
CA3151529A1 (en) * 2019-08-28 2021-03-04 Prolynx Llc Conjugated inhibitors of dna damage response
IL301558A (en) 2020-09-28 2023-05-01 Fundacio Inst De Recerca Biomedica Irb Barcelona Peptidic conjugates of sn38 useful in the treatment of cancer
US11976196B2 (en) * 2021-04-14 2024-05-07 Cambridge Crops, Inc. Silk packaging applications
WO2023186822A1 (en) 2022-03-28 2023-10-05 Hospital Sant Joan De Deu Peptidic water-soluble delivery system of anticancer drugs

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011042A (en) * 1997-10-10 2000-01-04 Enzon, Inc. Acyl polymeric derivatives of aromatic hydroxyl-containing compounds
JP2005537266A (ja) * 2002-07-12 2005-12-08 バイオマリン ファーマシューティカル インコーポレイテッド 加水分解性活性物質であるバイオポリマーコンジュゲートを作製するためのイソシアネートリンカーの使用
AU2003280592B2 (en) 2002-10-31 2008-12-18 Nippon Kayaku Kabushiki Kaisha High-molecular weight derivatives of camptothecins
US20040247624A1 (en) * 2003-06-05 2004-12-09 Unger Evan Charles Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
CA2537336C (en) 2003-09-17 2013-02-26 Nektar Therapeutics Al, Corporation Multi-arm polymer prodrugs
US7462627B2 (en) 2006-02-09 2008-12-09 Enzon Pharmaceuticals, Inc. Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
JP2010503708A (ja) * 2006-09-15 2010-02-04 エンゾン ファーマスーティカルズ インコーポレイテッド 多官能性リンカーを含む標的化ポリマープロドラッグ
KR20110075029A (ko) * 2008-10-21 2011-07-05 엔즌 파마슈티칼스, 인코포레이티드 7-에틸-10-하이드록시캄토테신의 다중-암 고분자 컨쥬게이트로 신경모세포종의 치료
AU2009316749A1 (en) 2008-11-18 2011-06-30 Baxter Healthcare S.A. Methods of determining polydispersity and/or molecular weight distribution of a polyethylene glycol sample
AU2010254013A1 (en) 2009-05-28 2011-11-24 Mersana Therapeutics, Inc. Polyal drug conjugates comprising variable rate-releasing linkers
PT2501413T (pt) * 2009-11-18 2019-07-10 Nektar Therapeutics Formas de sal de ácido de conjugados de polímero-fármaco
US8703907B2 (en) * 2010-05-05 2014-04-22 Prolynx Llc Controlled drug release from dendrimers
ES2584381T3 (es) * 2010-05-05 2016-09-27 Prolynx Llc Liberación controlada de compuestos activos desde conjugados macromoleculares
JP2012000072A (ja) * 2010-06-18 2012-01-05 Japan Health Science Foundation 新規な抗フィブリン抗体
TW201215412A (en) * 2010-08-30 2012-04-16 Sun Pharma Advanced Res Co Ltd Stable pharmaceutical composition
EP2654795B1 (en) * 2010-12-21 2018-03-07 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds
WO2013036857A1 (en) * 2011-09-07 2013-03-14 Prolynx Llc Sulfone linkers
MX371201B (es) * 2013-10-04 2020-01-22 Prolynx Llc Conjugados de liberación lenta de sn-38.

Similar Documents

Publication Publication Date Title
JP2016531895A5 (https=)
JP2018528184A5 (https=)
JP2013542247A5 (https=)
SG11201908101YA (en) Hepatitis b virus surface antigen inhibitor
ES2365988T3 (es) Agentes inmunoestimulantes no específicos.
HRP20141258T1 (hr) 6-amino-2-{[(1s)-1-metilbutil]oksi}-9-[5-(1-piperidinil)pentil]-7,9-dihidro-8h-purin-8-on maleat
RU2018105655A (ru) Комбинированная терапия с применением липосомального иринотекана и ингибитора parp для лечения рака
JP2013510120A5 (https=)
JP2018524298A5 (https=)
HRP20170433T1 (hr) Pripravci spoja za izmjenu lipidiranog imunološkog odgovora, formulacije, i postupci
JP2016506916A5 (https=)
JP2015505296A5 (https=)
JP2013510123A5 (https=)
RU2013121788A (ru) Ингибиторы репликации вич
JP2010270124A5 (https=)
JP2015532295A5 (https=)
WO2009095226A3 (en) NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS
EP3356355B1 (en) Compounds and combinations for the treatment of hiv
JP2017525718A5 (https=)
JP2016516074A5 (https=)
RU2017112308A (ru) Композиции и способы для лечения бессонницы
JP2019515908A5 (https=)
JP2017513809A5 (https=)
RU2017134443A (ru) Способ лечения с применением традипитанта
JP2015522033A5 (https=)